Cuong Viet Do

Cuong Viet Do was the founder of Callidus Biopharma, Inc. (founded in 2010) and served as Chairman from 2010 to 2013.
Mr. Do is the founder of M6P Therapeutics (founded in 2017) and serves as Chairman since 2017.
Mr. Do is the founder of Perceptivus LLC (founded in 2014) and serves as Chairman since 2014.
Mr. Do is the founder of Identifor, Inc. (founded in 2014) and serves as Chairman since 2014.
Current jobs include Chairman, President & Chief Executive Officer at BioVie, Inc. since 2016; Chief Executive Officer & Director at Option Therapeutics, Inc.; Director at Celebrate The Children; Director at True Image Interactive, Inc.; Independent Director at Adagene, Inc. since 2022; Director at ILiAD Biotechnologies LLC; Independent Director at Curve UK Ltd. since 2021; Director at Hope Portal Services, Inc.; Director at Seneca Therapeutics, Inc. since 2023; Independent Director at Spark I Acquisition Corp.
since 2021; Independent Director at Verde Bioresins Corp.; Trustee at Newark Academy; Owner at Do & Rickles Investments; Advisor at Autism Impact Fund; Member at Social Impact Partners.
Former jobs include Director at Wuxi PharmaTech (Cayman), Inc. from 2007 to 2011; Director & Senior Partner at McKinsey & Co., Inc. from 1989 to 2006; Director at National Youth Science Foundation, Inc.; Chief Strategy Officer & Executive Vice President at Merck & Co., Inc. from 2011 to 2014; Chief Strategy Officer & Senior Vice President at Lenovo Group Ltd. from 2006 to 2009; SVP-Corporate Strategy & Business Development at TE Connectivity Ltd. from 2009 to 2011; SVP-Corporate Strategy, Mergers & Acquisitions at TE Connectivity Corp.
in 2013; President at Samsung Global Strategy Group; President-Global Strategy at Samsung Group from 2015 to 2021.
Education includes undergraduate degree from Dartmouth College in 1988 and MBA from Tuck School of Business at Dartmouth in 1989.